| Date Filed | Type | Description |
| 10/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/05/2023 |
8-K
| Results of Operations and Financial Condition Interactive Data |
| 10/03/2023 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,038 shares
@ $827, valued at
$858.4k
Exercised 1,038 options to buy
@ $372.46, valued at
$386.6k
|
|
| 10/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/27/2023 |
SC 13D/A
| REGENERON PHARMACEUTICALS, INC. reports a 100% stake in Decibel Therapeutics, Inc. |
| 08/25/2023 |
4
| Fenimore Christopher R. (SVP Controller) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 5,198 shares
@ $842.66, valued at
$4.4M
Exercised 7,000 options to buy
@ $399.66, valued at
$2.8M
|
|
| 08/25/2023 |
4
| Landry Robert E (EVP Finance CFO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 223 shares
@ $844, valued at
$188.2k
|
|
| 08/25/2023 |
4
| POON CHRISTINE A (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 300 shares
@ $837.92, valued at
$251.4k
Sold 1,998 shares
@ $838.6, valued at
$1.7M
Sold 3,032 shares
@ $839.45, valued at
$2.5M
Sold 6,450 shares
@ $840.65, valued at
$5.4M
Sold 500 shares
@ $841.05, valued at
$420.5k
Exercised 12,280 options to buy
@ $273.67, valued at
$3.4M
|
|
| 08/25/2023 |
4
| Van Plew Daniel P (EVP & General Mgr, Industrial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 16,928 shares
@ $842.66, valued at
$14.3M
Sold 138 shares
@ $835.67, valued at
$115.3k
Sold 625 shares
@ $836.32, valued at
$522.7k
Sold 300 shares
@ $837.53, valued at
$251.3k
Sold 667 shares
@ $838.37, valued at
$559.2k
Sold 148 shares
@ $839.28, valued at
$124.2k
Sold 46 shares
@ $840.74, valued at
$38.7k
Sold 363 shares
@ $841.15, valued at
$305.3k
Sold 617 shares
@ $842.66, valued at
$519.9k
Sold 759 shares
@ $843.31, valued at
$640.1k
Sold 2,534 shares
@ $844.27, valued at
$2.1M
|
|
| 08/25/2023 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party: |
| 08/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/23/2023 |
4
| STAHL NEIL (EVP Research and Development) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 38,335 shares
@ $833.39, valued at
$31.9M
Sold 6,309 shares
@ $840.53, valued at
$5.3M
Sold 4,574 shares
@ $841.41, valued at
$3.8M
Sold 782 shares
@ $842.16, valued at
$658.6k
Exercised 50,000 options to buy
@ $399.66, valued at
$20M
|
|
| 08/23/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 853 shares
@ $829, valued at
$707.1k
Exercised 853 options to buy
@ $391.92, valued at
$334.3k
|
|
| 08/22/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/18/2023 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 08/11/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 853 shares
@ $789, valued at
$673k
Exercised 853 options to buy
@ $391.92, valued at
$334.3k
|
|
| 08/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/09/2023 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 08/03/2023 |
4
| RYAN ARTHUR F (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 2 shares
@ $732.76, valued at
$1.5k
Sold 4 shares
@ $733.51, valued at
$2.9k
Sold 18 shares
@ $734.56, valued at
$13.2k
Sold 22 shares
@ $735.55, valued at
$16.2k
Sold 16 shares
@ $736.64, valued at
$11.8k
Sold 17 shares
@ $737.5, valued at
$12.5k
Sold 10 shares
@ $738.45, valued at
$7.4k
Sold 5 shares
@ $739.63, valued at
$3.7k
Sold 3 shares
@ $740.52, valued at
$2.2k
Sold 2 shares
@ $741.42, valued at
$1.5k
Sold 1 shares
@ $744.66, valued at
$744.7 |
|
| 08/03/2023 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 250 shares
@ $744.66, valued at
$186.2k
|
|
| 08/03/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/06/2023 |
4
| McCourt Marion (EVP Commercial) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 250 shares
@ $710.09, valued at
$177.5k
|
|
| 07/06/2023 |
4
| RYAN ARTHUR F (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1 shares
@ $710.09, valued at
$710.1
Sold 1 shares
@ $711.95, valued at
$712
Sold 6 shares
@ $713.82, valued at
$4.3k
Sold 10 shares
@ $714.65, valued at
$7.1k
Sold 7 shares
@ $715.23, valued at
$5k
Sold 29 shares
@ $716.74, valued at
$20.8k
Sold 22 shares
@ $717.57, valued at
$15.8k
Sold 12 shares
@ $718.71, valued at
$8.6k
Sold 11 shares
@ $719.36, valued at
$7.9k
Sold 1 shares
@ $720.15, valued at
$720.2 |
|
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/18/2023 |
PX14A6G
| Form PX14A6G - Notice of exempt solicitation submitted by non-management: |
| 05/17/2023 |
4
| SCHLEIFER LEONARD S (President & CEO) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Gifted 53,807 shares
@ $0 |
|
|